{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:41:54Z","timestamp":1772620914117,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"LifeSaver Project","award":["101036702"],"award-info":[{"award-number":["101036702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07298-w","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:57:59Z","timestamp":1747947479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimizing resazurin-based viability assays for P-MSC\/TER308 cell line to enhance results reliability"],"prefix":"10.1186","volume":"18","author":[{"given":"Jessica","family":"Petiti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Revel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Divieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"7298_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/GCO.0000000000000156","volume":"27","author":"M Delnord","year":"2015","unstructured":"Delnord M, Blondel B, Zeitlin J. What contributes to disparities in the preterm birth rate in European countries? Curr Opin Obst Gynecol. 2015;27:133\u201342.","journal-title":"Curr Opin Obst Gynecol"},{"key":"7298_CR2","unstructured":"https:\/\/www.lifesaverproject.eu\/."},{"key":"7298_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature12831","volume":"504","author":"B Haibe-Kains","year":"2013","unstructured":"Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, Beck AH, Aerts HJWL, et al. Inconsistency in large Pharmacogenomic studies. Nature. 2013;504:389\u201393.","journal-title":"Nature"},{"key":"7298_CR4","doi-asserted-by":"publisher","first-page":"e1002165","DOI":"10.1371\/journal.pbio.1002165","volume":"13","author":"LP Freedman","year":"2015","unstructured":"Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13:e1002165.","journal-title":"PLoS Biol"},{"key":"7298_CR5","doi-asserted-by":"publisher","first-page":"12347","DOI":"10.3390\/s120912347","volume":"12","author":"SN Rampersad","year":"2012","unstructured":"Rampersad SN. Multiple applications of Alamar blue as an Indicator of metabolic function and cellular health in cell viability bioassays. Sensors. 2012;12:12347\u201360.","journal-title":"Sensors"},{"key":"7298_CR6","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","volume":"267","author":"J O\u2019Brien","year":"2000","unstructured":"O\u2019Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity: resazurin as a cytotoxicity assay. Eur J Biochem. 2000;267:5421\u20136.","journal-title":"Eur J Biochem"},{"key":"7298_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/bios12040196","volume":"12","author":"D Lavogina","year":"2022","unstructured":"Lavogina D, Lust H, Tahk M-J, Laasfeld T, Vellama H, Nasirova N, et al. Revisiting the Resazurin-Based sensing of cellular viability: widening the application horizon. Biosensors. 2022;12:196.","journal-title":"Biosensors"},{"key":"7298_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-1759(98)00028-3","volume":"213","author":"MM Nociari","year":"1998","unstructured":"Nociari MM, Shalev A, Benias P, Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods. 1998;213:157\u201367.","journal-title":"J Immunol Methods"},{"key":"7298_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/bios14040156","volume":"14","author":"J Petiti","year":"2024","unstructured":"Petiti J, Revel L, Divieto C. Standard operating procedure to optimize Resazurin-Based viability assays. Biosensors. 2024;14:156.","journal-title":"Biosensors"},{"key":"7298_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cells13231959","volume":"13","author":"J Petiti","year":"2024","unstructured":"Petiti J, Caria S, Revel L, Pegoraro M, Divieto C. Standardized protocol for Resazurin-Based viability assays on A549 cell line for improving cytotoxicity data reliability. Cells. 2024;13:1959.","journal-title":"Cells"},{"key":"7298_CR11","unstructured":"https:\/\/www.evercyte.com\/p-msc-tert308\/"},{"key":"7298_CR12","unstructured":"CLSI. Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures, 2nd Edition. 2012."},{"key":"7298_CR13","unstructured":"Committee for medicinal products for human use. ICH guideline Q2(R2) on validation of analytical procedures. 2022."},{"key":"7298_CR14","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/clinchem\/37.11.2002","volume":"37","author":"ID Hay","year":"1991","unstructured":"Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American thyroid association assessment of current free thyroid hormone and Thyrotropin measurements and guidelines for future clinical assays. The committee on nomenclature of the American thyroid association. Clin Chem. 1991;37:2002\u20138.","journal-title":"Clin Chem"},{"key":"7298_CR15","doi-asserted-by":"crossref","unstructured":"Divieto C, Sassi MP. A first approach to evaluate the cell dose in highly porous scaffolds by using a nondestructive metabolic method. Future Science OA. 2015;1:fso.15.58.","DOI":"10.4155\/fso.15.58"},{"key":"7298_CR16","first-page":"012051","volume":"459","author":"C Divieto","year":"2013","unstructured":"Divieto C, Revel L, Sassi G, Sassi MP. Uncertainty analysis of cell counting by metabolic assays. J Phys: Conf Ser. 2013;459:012051.","journal-title":"J Phys: Conf Ser"},{"key":"7298_CR17","unstructured":"Revel L, Santiano MTR. 15\/2022: manual micropipettes: internal procedure for periodic verification, data acquisition and processing. INRIM; 2022."},{"key":"7298_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpba.2019.04.042","volume":"172","author":"N Guichard","year":"2019","unstructured":"Guichard N, Rudaz S, Bonnabry P, Fleury-Souverain S. Validation and uncertainty Estimation for trace amounts determination of 25 drugs used in hospital chemotherapy compounding units. J Pharm Biomed Anal. 2019;172:139\u201348.","journal-title":"J Pharm Biomed Anal"},{"key":"7298_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrd3439-c1","volume":"10","author":"F Prinz","year":"2011","unstructured":"Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10:712\u2013712.","journal-title":"Nat Rev Drug Discov"},{"key":"7298_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd.2016.175","volume":"15","author":"P Horvath","year":"2016","unstructured":"Horvath P, Aulner N, Bickle M, Davies AM, Nery ED, Ebner D, et al. Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov. 2016;15:751\u201369.","journal-title":"Nat Rev Drug Discov"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07298-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:58:03Z","timestamp":1747947483000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07298-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7298"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07298-w","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}